Show simple item record

dc.contributor.authorDe Miguel Beriain, Iñigo
dc.contributor.authorLazcoz Moratinos, Guillermo ORCID
dc.contributor.authorSanz Echevarría, María Begoña
dc.date.accessioned2020-08-07T10:36:08Z
dc.date.available2020-08-07T10:36:08Z
dc.date.issued2020-07-14
dc.identifier.citationInformation, Communication & Society 23(8) : 1139-1153 (2020)es_ES
dc.identifier.issn1369-118X (Print)
dc.identifier.issn1468-4462 (Online)
dc.identifier.urihttp://hdl.handle.net/10810/45918
dc.description.abstractDiagnosis and clinical decision-making based on Machine Learning technologies are showing significant advances that may change the functioning of our health care systems. They promise more effective and efficient healthcare at a lower cost. Even though evidence suggests that all these promises have yet to be demonstrated in clinical practice, it is undeniable that these technologies are already re-signifying the relationships on the health care landscape, particularly in the physician-patient relationship, which we can already redefine as a ‘physician-computer-patient relationship’. This new scenario is undoubtedly promising, but it also poses some fundamental issues that need an urgent answer. An inappropriate use of Machine Learning might involve a dramatic loss in the patients’ rights to informed consent or possible discrimination reflecting their personal circumstances. Unfortunately, the traditional principles incorporated by medical law are insufficient to face this challenge. Our most recent regulatory framework, defined by the General Regulation on Data Protection, might be useful in order to avoid this scenario since it includes the right not to be subject to a decision based solely on automated processing. In this paper, however, we argue that this legal tool is adequate but not sufficient to address the legal, ethical and social challenges that Machine Learning technologies pose to patients’ rights and health care givers’ capacities. Therefore, further development of the regulation on this topic and the development of new actors such as the Health Information Counsellors, will be necessary.es_ES
dc.description.sponsorshipThis work was supported by Eusko Jaurlaritza [grant number Ayudas a grupos de investigación IT-1066-16]; H2020 Science with and for Society [grant number GRANT AGREEMENT NUMBER — 788039 — PANELFIT].es_ES
dc.language.isoenges_ES
dc.publisherTaylor and Francises_ES
dc.relationinfo:eu-repo/grantAgreement/EC/H2020/788039es_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.subjectmachine learninges_ES
dc.subjectblack boxes_ES
dc.subjectmedicinees_ES
dc.subjectGDPRes_ES
dc.subjecthealthcarees_ES
dc.titleMachine learning in the EU health care context: exploring the ethical, legal and social issueses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.holder© 2020 Informa UK Limited, trading as Taylor & Francis Groupes_ES
dc.relation.publisherversionhttps://www.tandfonline.com/doi/full/10.1080/1369118X.2020.1719185es_ES
dc.identifier.doi10.1080/1369118X.2020.1719185
dc.contributor.funderEuropean Commission
dc.departamentoesDerecho publicoes_ES
dc.departamentoeuZuzenbide publikoaes_ES


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record